Chemical inhibitors of ZNF37A include a range of compounds that interfere with various signaling pathways and molecular mechanisms within the cell, which are necessary for the proper functionality of ZNF37A. PD168393, an inhibitor of EGFR tyrosine kinase, can obstruct the kinase activity that ZNF37A may rely on for its transcriptional activation processes. This results in the inhibition of ZNF37A's ability to modulate gene expression effectively. Similarly, Y-27632 targets ROCK1 kinase, an enzyme that plays a critical role in actin cytoskeleton organization. The inhibition of ROCK1 by Y-27632 can alter the actin dynamics, which is imperative for chromatin remodeling and, thus, impede ZNF37A from accessing the DNA to perform its transcriptional duties. Another compound, SB431542, which inhibits ALK5, can suppress the TGF-β signaling pathway. Since ZNF37A could be involved in transcriptional responses to TGF-β signaling, the use of SB431542 can result in a decreased function of ZNF37A in these pathways.
LY294002 and Wortmannin both target PI3K, an upstream regulator of numerous signaling pathways, including those that ZNF37A may be involved in. By inhibiting PI3K, these compounds can diminish ZNF37A's functional role in the regulation of gene expression. U0126, which inhibits MEK1/2, can disrupt the MAPK/ERK pathway, a pathway that ZNF37A might use to mediate cellular responses to various stimuli, which in turn could hinder ZNF37A's transcriptional activity. Similarly, PP2's inhibition of Src family kinases has the potential to reduce ZNF37A's phosphorylation state, thereby weakening its DNA binding and transcriptional activity. SP600125 and SB203580, which inhibit JNK and p38 MAPK respectively, can interfere with ZNF37A's participation in cellular responses to stress and cytokine production. GW5074, an inhibitor of Raf-1 kinase, can disrupt signaling pathways that ZNF37A may use to influence cell growth and differentiation. Lastly, IKK-16's inhibition of IKK can attenuate NF-κB activation, which is essential for the regulation of genes involved in inflammatory responses and may also involve ZNF37A's regulatory functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 168393 | 194423-15-9 | sc-222138 | 1 mg | $162.00 | 4 | |
Inhibits EGFR tyrosine kinase which ZNF37A may interact with, leading to inhibition of ZNF37A-dependent transcriptional activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK1 which could alter actin dynamics, thereby inhibiting ZNF37A's ability to access chromatin and regulate gene transcription. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits ALK5, potentially reducing SMAD phosphorylation and ZNF37A-mediated transcriptional responses to TGF-β signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which is upstream of several signaling pathways that ZNF37A could act within, thereby inhibiting ZNF37A's functional role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially disrupting MAPK/ERK pathway and subsequent ZNF37A-mediated transcriptional activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, potentially reducing ZNF37A's phosphorylation and its subsequent DNA binding and transcriptional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could decrease ZNF37A's involvement in stress response gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially reducing ZNF37A's role in cytokine production and response to stress stimuli. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
Inhibits Raf-1 kinase, potentially disrupting ZNF37A-mediated signaling pathways involved in cell growth and differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could reduce the activity of transcription factors and coactivators associated with ZNF37A. | ||||||